- Home
- CCTG vs MBRX Comparison
CCTG vs MBRX Comparison
Compare CCTG & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCTG
- MBRX
- Stock Information
- Founded
- CCTG 1993
- MBRX 2015
- Country
- CCTG Hong Kong
- MBRX United States
- Employees
- CCTG N/A
- MBRX N/A
- Industry
- CCTG
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- CCTG
- MBRX Health Care
- Exchange
- CCTG Nasdaq
- MBRX Nasdaq
- Market Cap
- CCTG 14.9M
- MBRX 12.9M
- IPO Year
- CCTG 2024
- MBRX 2016
- Fundamental
- Price
- CCTG $1.06
- MBRX $0.31
- Analyst Decision
- CCTG
- MBRX Strong Buy
- Analyst Count
- CCTG 0
- MBRX 3
- Target Price
- CCTG N/A
- MBRX $5.33
- AVG Volume (30 Days)
- CCTG 5.9K
- MBRX 5.2M
- Earning Date
- CCTG 08-23-2025
- MBRX 08-13-2025
- Dividend Yield
- CCTG N/A
- MBRX N/A
- EPS Growth
- CCTG N/A
- MBRX N/A
- EPS
- CCTG N/A
- MBRX N/A
- Revenue
- CCTG $16,463,490.00
- MBRX N/A
- Revenue This Year
- CCTG N/A
- MBRX N/A
- Revenue Next Year
- CCTG N/A
- MBRX N/A
- P/E Ratio
- CCTG N/A
- MBRX N/A
- Revenue Growth
- CCTG 3.27
- MBRX N/A
- 52 Week Low
- CCTG $0.99
- MBRX $0.25
- 52 Week High
- CCTG $3.17
- MBRX $4.71
- Technical
- Relative Strength Index (RSI)
- CCTG 39.49
- MBRX 24.39
- Support Level
- CCTG $1.05
- MBRX $0.25
- Resistance Level
- CCTG $1.12
- MBRX $0.42
- Average True Range (ATR)
- CCTG 0.04
- MBRX 0.06
- MACD
- CCTG 0.01
- MBRX -0.03
- Stochastic Oscillator
- CCTG 46.67
- MBRX 13.07
About CCTG CCSC Technology International Holdings Limited
CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas and Asia.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.